Advanced search
Publication Cover
Ultrastructural Pathology Volume 46, 2022 - Issue 4
Submit an article Journal homepage
131
Views
3
CrossRef citations to date
0
Altmetric
Basic Research

Structural and ultrastructural changes in the skeletal muscles of dysferlin-deficient mice during postnatal ontogenesis

O. N. Chernovaa Human Morphology Department, North-Western State Medical University named after I.I. Mechnikov, Saint-Petersburg, Russian Federation;b Pathology and Forensic Medicine Department, Saint-Petersburg Medico-Social Institute, Saint-Petersburg, Russian FederationCorrespondence[email protected]
View further author information
,
I. A. Chekmarevac A.V. Vishnevsky National Medical Research Center of Surgery, Moscow, Russian FederationORCID Iconhttps://orcid.org/0000-0003-0126-4473View further author information
ORCID Icon,
M. O. Mavlikeevd Pathology Department, North-Western State Medical University named after I.I. Mechnikov, Saint-Petersburg, Russian FederationORCID Iconhttps://orcid.org/0000-0002-3799-6169View further author information
ORCID Icon,
I. A. Yakovleve Genotarget LLC, Moscow, Russian Federation;f Human Stem Cell Institute PJSC, Moscow, Russian FederationView further author information
,
A. P. Kiyasovg Morphology and General Pathology Department, Kazan (Volga region) Federal University, Kazan, Russian FederationView further author information
&
R.V. Deevd Pathology Department, North-Western State Medical University named after I.I. Mechnikov, Saint-Petersburg, Russian Federation;f Human Stem Cell Institute PJSC, Moscow, Russian FederationView further author information
Pages 359-367 | Received 06 Jul 2022, Accepted 20 Jul 2022, Published online: 26 Jul 2022

References

  • Bansal D, Campbell KP. Dysferlin and the plasma membrane repair in muscular dystrophy. Trends Cell Biol. 2004;14(4):206–213. doi:10.1016/j.tcb.2004.03.001.
  • de Luna N, Gallardo E, Soriano M, et al. Absence of dysferlin alters myogenin expression and delays human muscle differentiation “in vitro.” J Biol Chem. 2006;281(25):17092–17098. doi:10.1074/jbc.M601885200.
  • Kerr JP, Ward CW, Bloch RJ. Dysferlin at transverse tubules regulates Ca2+ homeostasis in skeletal muscle. Front Physiol. 2014;5:89. doi:10.3389/fphys.2014.00089.
  • Kerr JP, Ziman AP, Mueller AL, et al. Dysferlin stabilizes stress-induced Ca2-signaling in the transverse tubule membrane. Proc Natl Acad Sci. 2013;110(51):20831–20836. doi:10.1073/pnas.1307960110.
  • Sharma A, Yu C, Leung C, et al. A new role for muscle repair protein dysferlin in endothelial cell adhesion and angiogenesis. Arterioscler Thromb Vasc Biol. 2010;30(11):2196–2204. doi:10.1161/ATVBAHA.110.208108.
  • Anderson LV, Moss JA, Young C, et al. Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet. 1999;8(5):855–861. doi:10.1093/hmg/8.5.855.
  • Azakir BA, Di Fulvio S, Therrien C, et al. Dysferlin interacts with tubulin and microtubules in mouse skeletal muscle. PLoS One. 2010;5(4):e10122. doi:10.1371/journal.pone.0010122.
  • Di Fulvio S, Azakir BA, Therrien C, et al. Dysferlin interacts with histone deacetylase 6 and increases alpha-tubulin acetylation. PLoS One. 2011;6(12):e28563. doi:10.1371/journal.pone.0028563.
  • Bulankina AV, Thoms S. Functions of vertebrate ferlins. Cells. 2020;9(3):534. doi:10.3390/cells9030534.
  • Han WQ, Xia M, Xu M, et al. Lysosome fusion to the cell membrane is mediated by the dysferlin C2A domain in coronary arterial endothelial cells. J Cell Sci. 2012;125(5):1225–1234. doi:10.1242/jcs.094565.
  • Umakhanova Z, Bardakov S, Mavlikeev M, et al. Twenty-year clinical progression of dysferlinopathy in patients from Dagestan. Front Neurol. 2017;8:77. doi:10.3389/fneur.2017.00077.
  • Izumi R, Takahashi T, Suzuki N, et al. The genetic profile of dysferlinopathy in a cohort of 209 cases: genotype-phenotype relationship and a hotspot on the inner DysF domain. Hum Mutat. 2020;41(9):1540–1554. doi:10.1002/humu.24036.
  • Prelle A, Tankredi L, Sciacco M, et al. Retrospective study of a large population of patients with asymptomatic or minimally symptomatic raised serum creatine kinase levels. J Neurol. 2002;249(3):305–311. doi:10.1007/s004150200010.
  • Liu W, Pajusalu S, Lake NJ. Estimating prevalence for limb-girdle muscular dystrophy based on public sequencing databases. Genet Med. 2019;21:2512–2520. doi:10.1038/s41436-019-0544-8.
  • Durbeej M, Campbell K. Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr Opin Genet Dev. 2002;12(3):349–361. doi:10.1016/s0959-437x(02)00309-x.
  • McGreevy JW, Hakim CH, McIntosh MA, et al. Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy. Disease Models & Mechanisms. 2015;8(3):195–213. doi:10.1242/dmm.018424.
  • Hornsey MA, Laval SH, Barresi R, et al. Muscular dystrophy in dysferlin-deficient mouse models. Neuromuscular Disord. 2013;23(5):377–387. doi:10.1016/j.nmd.2013.02.004
  • Liesa MA, Palacin M, Zorzano A. Mitochondrial dynamics in mammalian health and disease. Physiol Rev. 2009;89(3):799–845. doi:10.1152/physrev.00030.2008.
  • Ho M, Post CM, Donahue LR, et al. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency. Hum Mol Genet. 2004;13(18):1999–2010. doi:10.1093/hmg/ddh212.
  • Demonbreun AR, Rossi AE, Alvarez MG, et al. Dysferlin and myoferlin regulate transverse tubule formation and glycerol sensitivity. Am J Pathol. 2014;184(1):248–259. doi:10.1016/j.ajpath.2013.09.009.
  • Grounds MD, Terrill JR, Radley-Crabb HG, et al. Lipid accumulation in dysferlin-deficient muscles. Am J Pathol. 2014;184(6):1668–1676. doi:10.1016/j.ajpath.2014.02.005.
  • Agarwall AK, Tunison K, Mitsche MA, et al. Insights into lipid accumulation in skeletal muscle in dysferlin-deficient mice. J Lipid Res. 2019;60(12):2057–2073. doi:10.1194/jlr.RA119000399.
  • Selcen D, Stilling G, Engel AG. The earliest pathologic alterations in dysferlinopathy. Neurology. 2001;56(11):1472–1481. doi:10.1212/wnl.56.11.1472.
  • Cenacchi G, Fanin M, De Giorgi LB, et al. Ultrastructural changes in dysferlinopathy support defective membrane repair mechanism. J Clin Pathol. 2005;58(2):190–195. doi:10.1136/jcp.2004.018978.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.